Relationship between imaging‐derived parameters and circulating microRNAs to study the degree of lung involvement in hospitalized geriatric patients with COVID‐19 pneumonia.

Aim: Chest computed tomography (CT) scan is useful to evaluate the type and extent of lung lesions in coronavirus disease 2019 (COVID‐19) pneumonia. This study explored the association between radiological parameters and various circulating serum‐derived markers, including microRNAs, in older patients with COVID‐19 pneumonia. Methods: A retrospective analysis was designed to study geriatric patients (≥75 years) with COVID‐19 pneumonia, who underwent chest CT scan on admission, and for whom clinical data and serum samples were obtained. To quantify the extent of lung involvement, CT‐score, the percentage of healthy lung (HL%), the percentage of ground glass opacity (GGO%), and the percentage of lung consolidation were assessed using computer‐aided tools. The association of these parameters with two circulating microRNAs, miR‐483‐5p and miR‐320b, previously identified as biomarkers of mortality risk in COVID‐19 geriatric patients, was tested. Results: A total of 73 patients with COVID‐19 pneumonia were evaluable (median age 85 years; interquartile range 82–90 years). Among chest CT‐derived parameters, the percentage of lung consolidation (HR 1.08, 95% CI 1.02–1.14), CT‐score (HR 1.14, 95% CI 1.03–1.25), and HL% (HR 0.97, 95% CI 0.95–0.99) emerged as significant predictors of mortality, whereas non‐significant trends toward increased mortality were observed in patients with higher GGO%. We also found a significant positive association between serum miR‐483‐5p and GGO% (correlation coefficient 0.28; P = 0.018) and a negative association with HL% (correlation coefficient −0.27; P = 0.023). Conclusions: Overall, the extent of lung consolidation can be confirmed as a prognostic parameter of COVID‐19 pneumonia in older patients. Among various serum‐derived markers, miR‐483‐5p can help in exploring the degree of lung involvement, due to its association with higher GGO% and lower HL%. Geriatr Gerontol Int 2024; 24: 962–972. [ABSTRACT FROM AUTHOR]